Expertise in
6
conditions

Min T. Xie

29 Wangjiang Rd, 
Chengdu, CN 
Expertise in
6
conditions
29 Wangjiang Rd, 
Chengdu, CN 

Overview

Min Xie practices practicing medicine in Chengdu, China.

Xie is highly rated in 6 conditions, according to our data. Their clinical expertise encompasses Asthma, Acute Pain, Cerebral Hypoxia, Pancreaticoduodenectomy, and Tissue Biopsy.

They are actively involved in clinical research, co-authoring 516 peer reviewed articles and participating in 1 clinical trial.

Locations

29 Wangjiang Rd, Chengdu, 610064, China
Other Locations
299 Bayi Road, Wuhan, 430072, China
366 Taihu Road, Taizhou, China
1095 Jiefang Avenue, Wuhan, 430030, China
No.139, Renmin Road, Changsha, China
28 Fuxing Road, Beijing, 100853, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-Blind, Multi-Center Phase II/III Clinical Study of PD-L1 Antibody/TGF-βRII (SHR-1701) Plus Tegafur Gimeracil Oteracil Potassium and Oxaliplatin Versus Placebo Plus Tegafur Gimeracil Oteracil Potassium and Oxaliplatin as Perioperative Treatment in Subjects With Resectable Gastric Cancer or Gastroesophageal Junction Cancer
A Randomized, Double-Blind, Multi-Center Phase II/III Clinical Study of PD-L1 Antibody/TGF-βRII (SHR-1701) Plus Tegafur Gimeracil Oteracil Potassium and Oxaliplatin Versus Placebo Plus Tegafur Gimeracil Oteracil Potassium and Oxaliplatin as Perioperative Treatment in Subjects With Resectable Gastric Cancer or Gastroesophageal Junction Cancer
Enrollment Status: Terminated
Publish Date: August 20, 2025
Intervention Type: Drug
Study Drug: SHR-1701 Injection
Study Phase: Phase 2/Phase 3

516 Total Publications

Spatiotemporal multiomics uncover tumor ecosystem dynamics during metastatic colonization.
Spatiotemporal multiomics uncover tumor ecosystem dynamics during metastatic colonization.
Journal: Science (New York, N.Y.)
Published: July 30, 2026

Frequently Asked Questions about Min T. Xie

Is Min T. Xie a top-rated expert for Asthma?

MediFind is an objective health platform that identifies experts based on real-world data. Min T. Xie is classified as an Advanced expert for Asthma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Min T. Xie participate in research or clinical trials?

Yes. Min T. Xie has published 516 articles and abstracts on conditions like Asthma. You can view a list of Min T. Xie's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Xie's expertise for a condition
ConditionClose
      View All 117 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile